Novo Nordisk’s Rally Meets a Revenue Reckoning: Buyback Momentum Clashes with 2026 Guidance
Novo Nordisk has staged a striking recovery over the past month, with the stock climbing 17% even as…
Future alternatives: what would be good for London clashes with Brussels
LondonA few days ago, German researcher Jannike Wachowiak, from the think tankUK in a Changing Europe, stated in…